Research | Morgan Lab

The main thrust of research in the Morgan laboratory is improving radiation and chemoradiation therapies through the development of novel molecularly targeted agents as tumor cell selective sensitizers, with a particular and emphasis on pancreatic cancer as well as lung and head neck cancers. This laboratory research program prioritizes pre-clinical research with strong clinical/translational relevance.